Li Xuan, MD
Nanfang Hospital, Southern Medical University
3
3
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Qifa Liu
Nanfang Hospital, Southern Medical University
Shared therapeutic areas:
Worked with same sponsors:
K A Bradstock), Dr.
Westmead Hospital
Shared therapeutic areas:
J Szer, Dr.
Royal Melbourne Hospital, Parkville, Australia
Shared therapeutic areas:
E Gluckman, Dr.
Hopital St Louis, Paris, France
Shared therapeutic areas:
J Rowe, Dr.
Rambam Medical Center, Haifa, Israel
Shared therapeutic areas:
G Lambertenghi-Deliliers, Dr.
Padiglione G Marcora, Ospedale Maggiore di Milano, Italy
Shared therapeutic areas:
T Ruutu, Dr.
Helsinki University CT. Rentral Hospital, Finland
Shared therapeutic areas:
A Ferrant, Dr
Cliniques Universitaires St Luc, Brussels, Belgium
Shared therapeutic areas:
K Kolbe, Dr.
Universitatsklinikum, Mainz, Germany
Shared therapeutic areas:
E Nikiforakis, Dr.
Evangelismos General Hospital, Athens, Greece
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT
The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT
The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or Without Sorafenib Maintenance
All 3 trials loaded